Meet the team

Genetic Alliance UK makes a huge difference to the lives of people with a genetic, rare or undiagnosed condition thanks to the strengths and commitment of our staff, trustees and members. 

Our highly experienced and dedicated staff lead on daily activities at the charity. With strong expertise across the charity, health, research and public policy sectors, we’re proud of the high impact that our staff team has in meeting our goals.

The overall strategic direction and governance of Genetic Alliance UK is overseen by our Board of Trustees. 9 of our trustees are elected by members to ensure that the challenges and opportunities facing our member organisations and the people they represent are at the heart of everything we do. 3 of our trustees are appointed to bring their diverse perspectives and professional expertise to the Board. Many of our trustees have lived experience of genetic and rare conditions, either personally or through a close family member.

Our staff

A man in a navy suit and dark red tie. He stands by the Thames river at the Westminster Parliament building.

Nick Meade

CEO
A man in a navy suit and dark red tie. He stands by the Thames river at the Westminster Parliament building.

Nick Meade

CEO

I have the privilege of leading the dedicated team at Genetic Alliance UK, working to improve the lives of individuals living with genetic, rare, and undiagnosed conditions. Having worked here for 20 years, my commitment lies in ensuring that the voices of our amazing member organisations and the people they support, remain central to everything we do. This is especially crucial as we contribute to the implementation of the UK Rare Disease Framework and engage in broader, evidence-based influencing.

I collaborate closely with our board of trustees to uphold transparent and effective governance, while driving the charity’s strategic direction. A significant part of my work is our advocacy, which is focused on enhancing outcomes for all those affected by genetic, rare, and undiagnosed conditions. We achieve this through evidence-based influencing and strategic campaigning. Our long-standing priorities include improving access to therapies for rare conditions, advancing genomic medicine, and ensuring the continued successful implementation of the UK Rare Disease Framework.

A headshot of Amy, from Genetic Alliance UK's Research team. She has shoulder length hair and smiles with a friendly smile. She stands by the Thames river at the Westminster Parliament building.

Amy Hunter

Director of Research
A headshot of Amy, from Genetic Alliance UK's Research team. She has shoulder length hair and smiles with a friendly smile. She stands by the Thames river at the Westminster Parliament building.

Amy Hunter

Director of Research

My job is to ensure that we are active in research that is relevant to individuals affected by genetic and rare conditions. We generally have a focus on cross-condition work and projects that will support our mission as an alliance and policy organisation. We often collaborate with university researchers and clinicians, and in addition to being active in research we facilitate the involvement of people living with genetic and rare conditions as partners in research. 

My academic background is in molecular biology and I have had several managerial roles in biomedical and psychosocial research. My personal motivation is to see real evidence-based improvements in the support that individuals living with genetic and rare conditions, and their families and carers, receive; our work at Genetic Alliance UK in health care research is significant and exciting for this reason.

Dr Anna Couturier

Director of Engagement and Impact

Dr Anna Couturier

Director of Engagement and Impact
My role is to make sure that the work we do at Genetic Alliance UK reaches the people who need it, and that the voices of those living with rare, genetic, and undiagnosed conditions genuinely shape what we do. That means working across membership engagement, communications and impact, and ensuring our members’ knowledge and experience carry weight wherever decision are being made.
I spent a decade leading EuroGCT and EuroStemCell, European consortia producing scientist-led, patient-informed resources on gene and cell therapy, based at the University of Edinburgh. My PhD research looked at how search algorithms and AI systems can expose patients to health misinformation online. That experience of auditing digital information environments is something I bring directly to my work here.
Good information and genuine trust are not small things when you are navigating a rare, genetic or undiagnosed condition, and finding ways to strengthen both is what brought me to Genetic Alliance UK.
A headshot of Jen, Genetic Alliance UK's Membership Communications Manager. She has her hair pinned up in plaits and she smiles wearing bright red lipstick. She stands by the Thames river at the Westminster Parliament building.

Jen Barley

Head of Membership and Communications
A headshot of Jen, Genetic Alliance UK's Membership Communications Manager. She has her hair pinned up in plaits and she smiles wearing bright red lipstick. She stands by the Thames river at the Westminster Parliament building.

Jen Barley

Head of Membership and Communications

As an engagement enthusiast, both professionally and personally, I have joined Genetic Alliance UK to manage many aspects of our member network including member communications, events and membership. I am always looking for ways to enhance member experience and to improve and diversify engagement.

I have worked in membership, engagement and communications for 20 years in a variety of roles at the Royal College of Emergency Medicine, The House of St Barnabas, Blind Veterans UK, RNIB and Channel 4.

Natalie Frankish

Director of Public Affairs (Genetic Alliance UK Lead for Scotland)

Natalie Frankish

Director of Public Affairs (Genetic Alliance UK Lead for Scotland)

I represent Scottish patients on a number of policy making groups, run our virtual patient panel and support patients wishing to start a support group for their condition through our Helping Patients Project. I studied Law and Politics before working on placement at the Scottish Government, developing adult support and protection legislation. I also worked for several years with families with long term health conditions. I am passionate about finding out what really matters to patients and their families and the best part of my job is seeing what a difference can be made when patients have a say in our their healthcare is delivered.

A headshot of Justin, Genetic Alliance UK's Corporate Fundraising Manager. He has a bald head and smiles with a friendly smile. He wears a navy suit and tie and stands by the Thames river at the Westminster Parliament building.

Justin Khodaiji

Head of Corporate Partnerships
A headshot of Justin, Genetic Alliance UK's Corporate Fundraising Manager. He has a bald head and smiles with a friendly smile. He wears a navy suit and tie and stands by the Thames river at the Westminster Parliament building.

Justin Khodaiji

Head of Corporate Partnerships

I lead the drive to secure funding for our Rare Disease UK campaign, Rare Disease Day, and our community appeal. I manage our key strategic partnerships with the life-sciences industry. I am passionate about forging innovative partnerships by developing new ways of aligning company strategy and organisational mission. I believe progress through partnerships is the key to effecting change.

Emma Hughes

Policy and Engagement Manager – Wales

Emma Hughes

Policy and Engagement Manager – Wales

My work includes policy, public affairs, communications and events. I work to generate and communicate a patient and family viewpoint on policy and practice relating to the development of genetics in healthcare in Wales. My background is in Law, Marketing and Communications, and I have previously worked in roles consulting with young people on disability rights and supporting projects benefiting the health and social care of children in developing countries. I believe that the patient voice is the single most powerful aspect in the development and implementation of new services, information, and support.

Miriam Ingram

Communications and Engagement Manager, SWAN UK

Miriam Ingram

Communications and Engagement Manager, SWAN UK

I am Communications and Engagement Manager for the support network SWAN UK (syndromes without a name), which is run by Genetic Alliance UK. SWAN UK is the only dedicated support network in the UK for families affected by undiagnosed genetic conditions. In my role, I work to ensure that our community of families are supported through regular communications, events and high quality information.I work with the SWAN UK community, the Genetic Alliance UK team, including our Parent Reps, as well as external stakeholders to make sure that the voices of the SWAN UK community are heard and that they are supported through a range of activities and opportunities. 

I manage all SWAN UK communications including our social media channels and newsletters and coordinate press enquiries.I am passionate about raising awareness of what it means to have an undiagnosed condition and SWAN UK and lead on the planning and communications for our annual awareness day, Undiagnosed Children’s Day.

A headshot of Rachel, Genetic Alliance UK's Policy team. She has long brown hair that falls behind her shoulder. She wears a white cardigan and glasses. She stands by the Thames river at the Westminster Parliament building.

Rachel McEleny

Public Affairs Manager
A headshot of Rachel, Genetic Alliance UK's Policy team. She has long brown hair that falls behind her shoulder. She wears a white cardigan and glasses. She stands by the Thames river at the Westminster Parliament building.

Rachel McEleny

Public Affairs Manager

I work with the Policy Team at Genetic Alliance UK to raise the profile of rare conditions in Parliament and assist on policy projects. I provide the secretariat for the All Party Parliamentary Group (APPG) on Rare, Genetic and Undiagnosed conditions and work with the policy team to deliver other parliamentary activities in Westminster. I support our Rare Disease UK campaign to ensure the implementation of the UK Rare Diseases Framework, this work includes providing the secretariat for the Rare Disease UK Patient Empowerment Group; a collective of patient representatives who work to support the advancement of the UK Rare Diseases Framework.

 

I have previously worked on the Rare2030 Project to influence and guide European rare disease policy and have worked on a project collating the impact of the Covid-19 pandemic on people living with rare conditions. I have an undergraduate degree in French and International Relations.

Headshot of Dani, Genetic Alliance UK's Senior Policy and Research Officer

Dani Bancroft

Senior Policy and Research Officer
Headshot of Dani, Genetic Alliance UK's Senior Policy and Research Officer

Dani Bancroft

Senior Policy and Research Officer

My role sits between the policy and research teams. I support policy development on topics like early detection and diagnosis, treatment and other health and social care services for people living with genetic, rare and undiagnosed conditions. For example, I support our members to amplify patient/public voice on reproductive choice and access to medicines with UK regulators. I also support the research team on projects on how to improve newborn screening programmes.

I have an MSc in Public Health from the London School of Hygiene & Tropical Medicine. Before Genetic Alliance UK, I was a researcher for a health policy consultancy where I largely focused on the early detection and diagnosis of cancers. Prior to this, I was a researcher in the global health field and a journalist for the life sciences. I am personally committed to the work Genetic Alliance UK does for its membership and excited to be a part of such a dedicated team representing people with lived experience.

A headshot of Jen, from Genetic Alliance UK's Research team. She has grey hair and smiles with a big friendly smile that shows her teeth. She stands by the Thames river at the Westminster Parliament building and wears a green scarf and brown cardigan.

Jennifer Jones

Research Associate
A headshot of Jen, from Genetic Alliance UK's Research team. She has grey hair and smiles with a big friendly smile that shows her teeth. She stands by the Thames river at the Westminster Parliament building and wears a green scarf and brown cardigan.

Jennifer Jones

Research Associate

My main task is to implement research studies and analyse data from people living with genetic, rare or undiagnosed conditions. We aim to better understand their lived experience and to feed into our policy work to ensure relevant and meaningful change. I completed my PhD at the London School of Hygiene and Tropical Medicine investigating the narratives of people who had been diagnosed with bladder or kidney cancer focussing on the time leading up to diagnosis.

I am committed to ensuring that the voices of those affected by genetic, rare or undiagnosed conditions are heard through robust and reliable research.

Anna Smith

Senior Communications Officer

Anna Smith

Senior Communications Officer

As Senior Communications Officer, I help support the smooth running of communications across the team, with a particular focus on newsletters, including Member News and Genetic and Rare News, scheduling and managing social media content, and keeping the website up to date. I have more than seven years’ experience in communications, which includes many years with NHS Hampshire and the Isle of Wight, where I developed a strong background in communications and digital engagement.

I am passionate about communications and the important role it plays in connecting people, sharing information clearly, and helping organisations build strong relationships with their audiences. This is particularly important at Genetic Alliance UK where there is such a massive emphasis on reducing isolation and uniting the genetic, rare and undiagnosed communities.

Our trustees

Professor Timothy Barrett

Chair

Professor Timothy Barrett

Chair

Timothy Barrett is a children’s doctor, having trained in London, Exeter and Birmingham, and has worked with children and adults living with rare conditions in the NHS for 40 years. He has established and delivers highly specialised national rare disease clinical services based at Birmingham Women’s and Children’s Hospital. He is professor of paediatrics at University of Birmingham, having led clinical trials in rare diseases and is now building rare disease treatment trials capacity across the UK 4 nations. He is a trustee for Alstrom syndrome UK and Wolfram syndrome UK, and non-exectutive advisor for Evelina Children’s Hospital. He is highly focused on advocating for and improving the lives of people living with rare conditions.

Tim Kamombo

Treasurer

Tim Kamombo

Treasurer

Tim is a Chartered Accountant with over 15 years in finance with his experience spanning financial services and healthcare sectors. He is a Finance Director at PensionBee. Prior to joining PensionBee, Timothy spent 11 years in audit with PwC (Zimbabwe, USA and UK) and Grant (Jersey, Channel Islands).

Aside the finance related work that Tim does, has served and still serving as a Non-Executive Director or Trustee or Audit Committee Member for a number of not-for-profit organizations in UK. Tim is passionate about bringing the change we want to see in scientific research, wellbeing of our communities and diagnostics. He has committed his time to work with organizations that are focused on bringing about this change.

Lara Bloom

Lara Bloom

Lara is the President and CEO of The Ehlers-Danlos Society which is responsible for globally raising awareness of rare, chronic, and invisible diseases, specialising in the Ehlers-Danlos syndromes (EDS), hypermobility spectrum disorders (HSD), and related conditions. Lara leads coordinated medical collaboration, raising funds for research and focuses on global progression, education and awareness. Her passion is pushing boundaries and fighting for progression in patient engagement and global collaboration, and she was officially appointed an Academic Affiliate Professor of Practice in Patient Engagement and Global Collaboration at Penn State College of Medicine, USA, in March 2020. Lara is a published author in various renowned journals and speaks worldwide at conferences, policy meetings, corporate and fundraising events and academic lectures as an expert keynote speaker. 

Silvia Cerolini

Silvia Cerolini

Silvia Cerolini is a rare disease advocate and healthcare transformation leader with over 20
years of experience driving innovation across the life sciences, consumer and not-for-profit
sectors.

As the mother of a daughter living with a rare inherited retinal disease, Silvia brings lived
experience as a carer alongside deep professional expertise. She is the Founder and CEO
of Eyes on the Future, a UK charity member of Genetic Alliance UK, and coordinator of
the Global RDH12 Alliance, an international network dedicated to advancing treatments for
RDH12-related inherited retinal disease. Silvia has played a leading role in building
innovative patient–industry partnerships and creating a global network that brings together
families, researchers, clinicians, industry and regulators to accelerate research from the
laboratory into clinical trials, helping reshape the future of rare disease drug development.

Professionally, Silvia is Head of Transformation at Sanofi UK & Ireland, where she leads
enterprise transformation, digital and AI innovation, and strategic partnerships across the
healthcare ecosystem.

Passionate about transforming the future of life sciences, Silvia has been featured in national
and international media and a regular speaker on patient partnership and innovation. She is
a strong advocate for reimagining how patients, industry, academia and regulators work
together to accelerate therapies for rare diseases towards a future of precision medicine.

Headshot of Toby Hannam, his body faces to the right and he wears a suit with a light blie shirt and dark red tie. He faces his head toward to camera with short curled hair and teeth slightly showing with his smile

Toby Hannam

Headshot of Toby Hannam, his body faces to the right and he wears a suit with a light blie shirt and dark red tie. He faces his head toward to camera with short curled hair and teeth slightly showing with his smile

Toby Hannam

Toby is a health policy and public affairs expert who has spent the last decade working in consultancy and in the UK parliament. Throughout his career, he has developed a deep knowledge of the UK health policy environment, with a particular interest in diagnostics and genomics. Toby supports clients to develop successful engagement campaigns that ultimately improve patient outcomes and service delivery. Through these experiences he was introduced to the leadership of the Genetic Alliance. Having personally experienced the transformational nature of a fast and accurate diagnosis, Toby has a particular passion in utilising his skills and knowledge to support people living with genetic conditions and their families. 

Kirsty Hoyle

Kirsty Hoyle

Kirsty Hoyle is CEO of Metabolic Support and an experienced charity leader, strategist and change-maker. She is a leading voice behind the Living Well movement, which seeks to transform how quality of life is understood and supported for people living with rare conditions.

Previously CEO of Transport for All, Kirsty campaigned for the rights of disabled and older people to travel with freedom and independence. She has also held roles at Sense, Diabetes UK and Help for Heroes, working across the charity, public and private sectors to create lasting change and demonstrate the connection between accessible services, wellbeing and community participation.

Before moving into full-time charity leadership, Kirsty was an internationally recognised specialist in disability and cultural access. As founder of Include Arts, she led the pioneering national Relaxed Performance Project and shared her approach internationally through the British Council. Her work helped arts organisations around the world create more welcoming and inclusive experiences for disabled audiences and their families.

Deb Lancaster

Deb Lancaster

Deb brings over 40 years of experience across the pharmaceutical and life sciences sectors,
including 25 years in oncology and more than a decade in executive leadership roles with
major global companies, with a focus on Market Access.

In 2021, Deb moved into the public sector as Executive Director of Scientific Partnership at
Genomics England, where she championed scientific collaboration and the advancement of
genomic research in rare diseases and cancer.

Since retiring from Genomics England in April 2026, Deb has continued to contribute to the
sector through her leadership of a working group for the Rare Therapies Launchpad, now
adopted by LifeArc. The initiative aims to develop new pathways to access individualised therapies for people living with very rare conditions.

Alongside her extensive expertise in pharmaceutical commercial strategy, market access
and leadership, Deb also serves as a Trustee of Myeloma UK, a position she has held for
the past two years. This reflects her commitment to improving access to treatment,
advancing research and making a meaningful difference to the lives of people affected by
serious and rare conditions.

Deb lives in St Albans with her partner and two sons. Outside work, she enjoys live music,
keeping active at the gym and travelling.

headshot of Genetic Alliance UK Trustee, Emily Merrell

Emily Merrell

headshot of Genetic Alliance UK Trustee, Emily Merrell

Emily Merrell

Emily has worked within the Healthcare sector for 25+ years with global development experience spanning Biotech, Pharma, CROs, and public sector. In addition to roles in drug development, she has also worked as a consultant within the NHS where she developed a programme of population health management- designed to improve health outcomes for local populations including increased health equity and preventative care. During this time, she also co-led the development and implementation of a virtual COVID hospital that resulted in improved outcomes for COVID-19 patients during the pandemic. Whilst at the Cell and Gene Therapy Catapult within the UK Emily was Head of The Advanced Therapies Treatment Centre (ATTC) Network Coordination. This involved driving a National UK based consortia of Academia, Clinical Institutions and Industry partners to develop the necessary infrastructure for the clinical development and adoption of advanced therapies into the NHS within the UK. Her clinical development experience spans all therapeutic areas and all stages of the clinical development lifecycle, from First- In- Human trials to Long-Term Follow Up and Post Marketing surveillances. Emily’s most recent role at ICON was as Head of Cell & Gene Therapy development, driving the strategic and operational growth of the ICON’s expertise and capabilities which has so far supported the delivery of 170+ Cell and Gene Therapy Clinical Trials over the last five years across a diverse range of therapeutic areas, development phases and technologies, some of which will be of benefit to the rare community. Previously, she had the privilege of supporting the mental health charity ‘Mind’ as a Trustee which Emily found to be a thoroughly rewarding experience. She has a deep passion and enthusiasm for enabling new and different ways of working, challenging ‘traditional models’ and cultivating more collaborative working within and across organisations as the driving force of improved health outcomes for populations. Outside of work, she enjoys keeping fit at the gym and practicing Pilates. Her two teenagers also keep her busy and she is currently (slowly) teaching herself how to play the piano.

A woman in a silm light pink shirt and jeans. She has blonde hair and blue eyes and has a kind smile looking towards the camera

Rebecca Middleton

A woman in a silm light pink shirt and jeans. She has blonde hair and blue eyes and has a kind smile looking towards the camera

Rebecca Middleton

Founder and CEO of Hereditary Brain Aneurysm Support, a UK first charity supporting families and individuals living with familial brain aneurysm syndrome, raising awareness and research into the genetic condition.

Rebecca is an experienced patient advocate and founding member of the Participant Panel at Genomics England (2016 – 2024) and former Vice Chair of Rare Conditions and Vice Chair of the Communications Working Group. Current member of the NHS Strategic Implementation Group for the Generation Study and Chair of a key working group of the study that aims to sequence the genomes of over 100,000 newborns.

Rebecca also founded The Vascular Voice Network which brings together around 25 large and small charities and organisations on a level playing field from the vascular condition eco system. The Network aims to be a national vascular champion for patients and communities, uniting through our four key principles of commonality, collaboration, care and communication and clinical and scientific research.

Rebecca is a current member of the East of England PPV Panel, as well as member of several advisory patient and engagement groups, working across the rare condition eco system.

With a strong strategic background and a track record of successful stakeholder engagement, she is a leader, a collaborative team player and a trusted voice in her field. She is formerly a journalist and an award-winning PR and communications specialist with over 20 years of experience and expertise in international corporate communications, community affairs and reputation management.

Dr Shehla Mohammed

Dr Shehla Mohammed

Shehla is a paediatric clinical geneticist with 28 years’ experience predominantly in rare genetic conditions and in the care of children and families with complex life-limiting disorders. Until 2017, she had been Head of Service of the Guy’s Regional Genetics Service for 20 years. Shehla has a special interest in translating new technologies into a clinical setting and to enable the successful delivery of multidisciplinary and patient-focused services. With a strong clinical and managerial background she has successfully advocated for rare diseases and has developed and leads national Highly Specialist Services for a number of complex disorders with colleagues from the dedicated Rare Diseases Centre at St Thomas Hospital, London. Shehla has been the Principal Investigator in Phase III clinical trials whilst fostering international collaborations to improve patient outcomes. She is currently a member of the Highly Specialised Technologies Evaluation Committee at NICE. 

Dr Kiki Syrad

Dr Kiki Syrad

Dr Kiki Syrad is the Director of Research and Innovation at Great Ormond Street Hospital (GOSH), a role she has held since November 2023. She joined the hospital from the charity sector, where she spent more than 15 years in senior leadership roles.

Before taking up her current post, Kiki served as Director of Grants and Impact at Great Ormond Street Hospital Charity, leading the development of two five‑year research strategies that resulted in £120m of investment in research across the UK. Earlier in her career, she was Head of Research and Funding at Breast Cancer Now.

Kiki completed her PhD at the University of Melbourne, focusing on cancer therapies. As a
researcher, she worked within the Angiogenesis Group at the Weatherall Institute of Molecular Medicine in Oxford, contributing to the identification of novel cancer markers and investigating a potential therapeutic cancer target.

She currently serves as a trustee of the UCL ICH – The Child Health Research Charitable Incorporated Organisation (CIO). She has previously been a trustee of both the National Children’s Bureau and NHS Charities Together, bringing experience across children’s services, health policy and the wider NHS charity sector.

Dr Mike Winter

Dr Mike Winter

Dr Mike Winter joins Genetic Alliance UK as a Trustee from February 2025. He retired from full time employment in August 2019 having been the Medical Director for Specialist Services in NHS Scotland since 2008. His earlier clinical career was as a GP and a Psychiatrist; and he continued to champion the importance of the patient and family voice in his role as the commissioner of specialist services in Scotland and as the NHS Scotland representative at meetings with NHS England, including as a member of RDAG (Rare Diseases Advisory Group). Listening to, and advocating for, those with lived experience of a condition is central to his way of working, combining this with an extensive knowledge of how health and care systems work across the UK.

Mike has long experience of being a Charity Trustee, most recently with Girl Guiding Scotland where he served two terms of office as their external trustee working with both volunteers and staff to help reshape their organisational and governance arrangements to strengthen delivery of their published strategy. Having been a trustee with the Vine Trust, an international charity based in Edinburgh, he continues to support their work in delivering primary care health services in Amazonian Peru, and on Lake Victoria in Tanzania, as well as providing housing support for families in Tanzania.

Mike is based in Edinburgh, is married with grown up children and enjoys his role as a grandfather.

He is a keen photographer and a competent cook. He is looking forward to bringing 35years of senior management and governance responsibilities within the NHS and in charitable work to complement the skills already present within the Genetic Alliance UK Trustee Board.